Skip to content

Mechanical Power-Guided Lung Protective Ventilation (VentCoach) in Acute Hypoxemic and/or Hypercapnic Respiratory Failure

Mechanical Power-Guided Lung Protective Ventilation (VentCoach) in Acute Hypoxemic and/or Hypercapnic Respiratory Failure: A Feasibility, Double Arm, Single-blinded Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07294768
Enrollment
18
Registered
2025-12-19
Start date
2023-10-11
Completion date
2024-05-17
Last updated
2025-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mechanical Ventilation

Brief summary

The purpose of this research is to evaluate a different way of using the mechanical ventilator device to help better protect the lungs while the patient recovers. We will compare VentCoach to the current standard mechanical ventilation techniques used in our Intensive Care Units.

Interventions

OTHERVentCoach

VentCoach, a mechanical power-guided lung protective ventilation protocol, will be used to set ventilator adjustments. VentCoach ventilator assessments and adjustments will be performed within one hour after enrollment, and then every 4 hours thereafter

OTHERStandard of Care

Intubated patients will be managed per the standard of care ARDSnet-based mechanical ventilation management at Mayo Clinic, with routine RT/MD assessments, and ventilator setting changes as necessary for the treatment of the patient.

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with acute hypoxemic and/or hypercapnic respiratory failure. * Patients requiring intubation and mechanical ventilation for more than 24 hours. * VentCoach protocol is specific to volume controlled continuous mandatory ventilation (S-CMV). * Patient who are admitted to RMH 10-3/10-4 and MB 6BGF ICUs. * Age greater than or equal to 18 years. * Patient's legal representative should be able to provide informed consent to the study. Any participant speaking any language will be offered participation.

Exclusion criteria

* Intubation and mechanical ventilation for airway protection in the setting of procedures/surgeries, e.g. interventional radiology, surgery, or endoscopy. * Intubation and mechanical ventilation due to drug overdose with expected extubation of less than 24 hours. * Intubation and mechanical ventilation in the setting of cardiac arrest. * Intubation and mechanical ventilation for a primary neurological etiology, e.g. increased intracranial pressure, tumor mass effect, ischemic/hemorrhagic stroke, status epilepticus, etc. * Mechanical ventilation to be guided by esophageal balloon. * Subject deprived of freedom, minor, subject under a legal protective measure. * Change in end-of-life decision anticipated after enrollment (or estimated 6-month mortality rate of greater than 50%). Note: prone positioning is not a contraindication for participation.

Design outcomes

Primary

MeasureTime frameDescription
Adherence to the VentCoach protocol1 yearTotal number of patients to achieve adherence will be defined as documented reduction in mechanical power (MP) or MP less than 12 J/min, in the 16 patients assigned to the VentCoach group

Secondary

MeasureTime frameDescription
Time to removal from ventilator1 yearTime to successful extubation, allocation to ECMO, or death reported in number of days
Incidence of patient-ventilator dyssynchrony1 yearNumber of patients to experience patient-ventilator dyssynchrony, defined as double triggering and flow starvation
Overall use of sedation1 yearTotal use of analgesia, converted to morphine equivalent
Overall use of paralytics1 yearTotal number of patients to require paralytics: bolus and infusion of neuromuscular blockade outside intubation procedure
Oxygenation indexBaseline, end of treatment (up to 14 days)Oxygenation index is calculated by the following equation: mean airway pressure MAP (in cmH2O) × FiO2 × 100 ÷ PaO2 and is reported as a single number.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026